Adial Pharmaceuticals (ADIL) Times Interest Earned (2017 - 2025)
Adial Pharmaceuticals (ADIL) posted Times Interest Earned of -$22.96 for Q1 2025, down 207.98% sequentially from -$7.46 in Q4 2024, and up 93.69% YoY from -$11.86 in Q1 2024.
Adial Pharmaceuticals (ADIL) Times Interest Earned (2017 - 2025) Analysis & Trends
Adial Pharmaceuticals has reported Times Interest Earned for 9 years, with the latest figure at -$22.96 in Q1 2025.
- Quarterly Times Interest Earned rose 93.69% year-over-year to -$22.96 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was -$35.97 (down 6.97% YoY) and the FY2025 annual result came in at -$0.47, up 12.53% from the prior year.
- Times Interest Earned slipped to -$22.96 in Q1 2025 per ADIL's latest filing, from -$7.46 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.64 in Q3 2021 and troughed at -$19803.3 in Q3 2022.
- A 5-year average of -$1371.3 and a median of -$25.72 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2021 and 2022: Times Interest Earned surged 99.81% in 2021, then sank 3102853.37% in 2022.
- Over 5 years, Times Interest Earned stood at -$264.97 in 2021, then soared by 93.52% to -$17.16 in 2022, then jumped by 34.6% to -$11.22 in 2023, then soared by 33.55% to -$7.46 in 2024, then slumped by 207.98% to -$22.96 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$22.96, -$7.46, and -$122.23 for Q1 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Adial Pharmaceuticals | 29.02 Mn | 29.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -22.96 |
| Dec 31, 2024 | -7.46 |
| Sep 30, 2024 | -122.23 |
| Jun 30, 2024 | -282.35 |
| Mar 31, 2024 | -364.07 |
| Dec 31, 2023 | -11.22 |
| Jun 30, 2023 | -28.47 |
| Mar 31, 2023 | -162.06 |
| Dec 31, 2022 | -17.16 |
| Sep 30, 2022 | -19,803.28 |
| Jun 30, 2022 | -842.55 |
| Mar 31, 2022 | -4.28 |
| Dec 31, 2021 | -264.97 |
| Sep 30, 2021 | -0.64 |
| Jun 30, 2021 | -2.87 |
| Mar 31, 2021 | -3.62 |
| Dec 31, 2020 | -0.57 |
| Sep 30, 2020 | -3.18 |
| Jun 30, 2020 | -1,515.66 |
| Mar 31, 2020 | -221.43 |